These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cardiovascular and autonomic effects of muscle relaxants. Scott RP; Basta SJ Compr Ther; 1985 Mar; 11(3):56-67. PubMed ID: 2579761 [No Abstract] [Full Text] [Related]
43. [Serotonin as a regulator of autonomic tonus]. WALAWSKI J Acta Physiol Pol; 1959; 10(2):278-9. PubMed ID: 13660894 [No Abstract] [Full Text] [Related]
44. Guidelines to the use of laboratory animals: what about neuromuscular blocking agents? Marsch SC; Studer W Cardiovasc Res; 1999 Jun; 42(3):565-6. PubMed ID: 10533592 [No Abstract] [Full Text] [Related]
45. [Vegetative effects of serotonin in man]. LAFON R; DUC N; MINVIELLE J; FAURRE LE Therapie; 1957; 12(3):371-5. PubMed ID: 13455609 [No Abstract] [Full Text] [Related]
46. Benzylisoquinolinium Muscle Relaxants: Innovations asn Issues. Proceedings from a meeting. Geneva, Switzerland, January 14-16, 1994. Acta Anaesthesiol Scand Suppl; 1995; 106():1-95. PubMed ID: 8533536 [No Abstract] [Full Text] [Related]
47. Monitoring Neuromuscular Function. Ortega R; Brull SJ; Prielipp R; Gutierrez A; De La Cruz R; Conley CM N Engl J Med; 2018 Jan; 378(4):e6. PubMed ID: 29365307 [No Abstract] [Full Text] [Related]
48. Use of neuromuscular blocking drugs in scientific investigations involving animal subjects. The benefit of the doubt goes to the animal. Drummond JC; Todd MM; Saidman LJ Anesthesiology; 1996 Oct; 85(4):697-9. PubMed ID: 8873538 [No Abstract] [Full Text] [Related]
49. Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management. Abel M; Book WJ; Eisenkraft JB Drug Saf; 1994 Jun; 10(6):420-38. PubMed ID: 7917072 [TBL] [Abstract][Full Text] [Related]
50. Three types of muscarinic receptors? [proceedings]. Barlow RB; Burston KN; Vis A Br J Pharmacol; 1980 Jan; 68(1):141P-142P. PubMed ID: 7357156 [No Abstract] [Full Text] [Related]
51. A comparison of the effects of pancuronium bromide and its monoquaternary analogue, ORG NC 45, on autonomic and somatic neurotransmission in the rat. Docherty JR; McGrath JC Br J Pharmacol; 1980; 71(1):225-33. PubMed ID: 6110454 [TBL] [Abstract][Full Text] [Related]
52. Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum. Nedoma J; Dorofeeva NA; Tucek S; Shelkovnikov SA; Danilov AF Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):176-81. PubMed ID: 4010794 [TBL] [Abstract][Full Text] [Related]
54. Proceedings: effects of non-depolarizing neuromuscular blocking agents on vagal and sympathetic mechanisms in cats. Hughes R; Chapple DJ Br J Anaesth; 1975 May; 47(5):633-4. PubMed ID: 1138787 [No Abstract] [Full Text] [Related]
55. Neuromuscular blocking agents in equine anesthesia. Klein LV Vet Clin North Am Large Anim Pract; 1981 May; 3(1):135-61. PubMed ID: 7023008 [No Abstract] [Full Text] [Related]
56. Neuromuscular and autonomic actions of four chandonium analogues [proceedings]. Teerapong P; Marshall IG; Harvey AL; Singh H; Paul D; Bhardwaj TR; Ahuja NK J Pharm Pharmacol; 1977 Dec; 29 Suppl():80P. PubMed ID: 22715 [No Abstract] [Full Text] [Related]
57. Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings]. Marshall RJ; Ojewole JA Br J Pharmacol; 1979 May; 66(1):77P-78P. PubMed ID: 454962 [No Abstract] [Full Text] [Related]
58. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants. Hilgenberg JC Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564 [No Abstract] [Full Text] [Related]